SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-12-067664
Filing Date
2012-12-12
Accepted
2012-12-12 16:59:59
Documents
2
Period of Report
2012-12-09
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K v330241_8k.htm 8-K 16294
2 EXHIBIT 99.1 v330241_ex99-1.htm EX-99.1 8246
  Complete submission text file 0001144204-12-067664.txt   26023
Mailing Address 605 THIRD AVENUE 34TH FLOOR NEW YORK NY 10158
Business Address 605 THIRD AVENUE 34TH FLOOR NEW YORK NY 10158 646-666-3188
BRAINSTORM CELL THERAPEUTICS INC. (Filer) CIK: 0001137883 (see all company filings)

IRS No.: 208133057 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-54365 | Film No.: 121259760
SIC: 2836 Biological Products, (No Diagnostic Substances)